Discontinued — last reported Q4 '15
Higher charges indicate significant organizational change or downsizing, which may lead to future cost savings but often signal short-term disruption or declining regional performance.
This metric captures specific expenses recognized within the Europe, Africa, and Middle East segment directly attributab...
Comparable to 'special items' or 'restructuring costs' reported by global life sciences companies, which are typically excluded from adjusted earnings to reflect core operational health.
zts_segment_europe_africa_middle_east_restructuring_charges